- Trust’s data-sharing agreement does not comply with national rules
- NHSE “exclusivity” guidance released after RNOH’s agreement was struck
- But campaign group raises concerns over deal
An agreement to share patient data struck between a specialist trust and a start-up company does not comply with NHS England guidance, HSJ has discovered.
The 10-year agreement between the Royal National Orthopaedic Hospital and population health company Naitive Technologies contravenes NHS England and government guidance, which warns against granting “exclusive” use of patient data to private companies.
The data-sharing deal was struck in July 2018 — a year before the national guidance was released in 2019. The deal has only recently come to light through a published response to a freedom of information request to the trust.
Campaign group MedConfidential, which submitted the FOI request, said: “Arrangements which contravene NHS guidelines undermine patients’ confidence that their data is safe with the NHS.”
RNOH said it is currently in negotiations with Naitive to amend the agreement to reflect current NHS guidance, particularly around the exclusivity issue. It said it had “conducted [itself] appropriately at all times” and taken account of the guidance around exclusivity in subsequently agreed contracts.
The trust at first denied knowledge of the deal in their initial response to MedConfidential’s FOI request. But later admitted this was an error and released the details.
RNOH has previously said Naitive Technologies is using the data for a project to create AI models to help in the early diagnosis of osteoporosis.
The trust refused to provide HSJ with the number of patients whose data has been shared because it said this information is “commercially sensitive to Naitive”. It did confirm it included X-ray data and said that “no identifiable patient data leaves the trust”.
It added: “As part of a commercial arrangement, we share anonymised data to develop technology to improve diagnostics for patients.”
CEO role
RNOH’s then CEO Rob Hurd joined the Naitive Technologies board in July 2018 — the same time as the data agreement was signed — in what the trust said was a “representative” role.
Mr Hurd stepped down from the company’s board in February 2020 when the relationship between the trust and the company “moved from… a research collaboration to the RNOH now considering a potential commercial relationship with the company,” according to a declaration of interest published in the trust’s 2018-19 annual report.
The trust said Mr Hurd received no pay for this role with Naitive Technology, and he did not hold shares. Mr Hurd is now chief executive officer of North West London Integrated Care Board.
Naitive Technologies did not reply to a request for comment.
HSJ Patient Safety Congress| 16-17 September 2024, Manchester
The HSJ Patient Safety Congress will return on 16-17 September 2024 in Manchester.
The 2024 theme is Honest Conversations: Creating safety in a system under pressure. Attending the Congress will allow you to be part of these vital discussions, which will explore how safety approaches contribute to reducing avoidable harm and improving the quality of patient care across the system.
Join 1000+ of your peers from across the NHS and wider system, including leaders, managers, clinicians and patient representatives. Over 2 days, 11 content streams with 37+ hours of engaging and interactive education and 120+ expert speakers joining the panels.
Source
FOI requests, information provided to HSJ
Source Date
- November 2023 - August 2024
No comments yet